TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
Vasoconstrictor medicines belong to a class of drugs known as pressor drugs because they raise arterial pressure. These medications induce blood vessels to constrict by contracting the smooth muscle in the vessels. Because mean arterial pressure is determined by the product of systemic vascular resistance and cardiac output, constriction of arterial vessels raises systemic vascular resistance, which leads to a rise in arterial blood pressure. The Frank-Starling mechanism, which increases arterial pressure, increases venous blood pressure and increases cardiac preload and cardiac output when venous arteries are constricted.
This report contains market size and forecasts of Vasoconstrictor Drugs in Global, including the following market information:
Global Vasoconstrictor Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Vasoconstrictor Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vasoconstrictor Drugs include Pfizer, Fresenius Kabi, Par Pharmaceutical, Ferring B.V., Endo International, Astellas Pharma, Hybio Pharmaceutical, Cumberland Pharmaceuticals and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Vasoconstrictor Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vasoconstrictor Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Vasoconstrictor Drugs Market Segment Percentages, by Type, 2021 (%)
Tablet
Injection
Others
Global Vasoconstrictor Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Vasoconstrictor Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Vasoconstrictor Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Vasoconstrictor Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vasoconstrictor Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Vasoconstrictor Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Fresenius Kabi
Par Pharmaceutical
Ferring B.V.
Endo International
Astellas Pharma
Hybio Pharmaceutical
Cumberland Pharmaceuticals
AstraZeneca
Novartis
Bayer
Shanghai Soho-Yiming Pharmaceuticals
| Report Attributes | Report Details |
|---|---|
| Report Title | Vasoconstrictor Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2021 |
| Forecast Year | 2029 |
| Number of Pages | 68 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions ?
